NCT02891148View on ClinicalTrials.gov

Single Rising Dose Study of BI 690517 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 29, 2016

Primary Completion Date

December 12, 2016

Study Completion Date

December 12, 2016

Conditions
Healthy
Interventions
DRUG

BI 690517

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY